These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 33976722)
1. The natural compound n-butylidenephthalide kills high-grade serous ovarian cancer stem cells by activating intrinsic apoptosis signaling pathways. Chang YH; Wu KC; Ding DC J Cancer; 2021; 12(11):3126-3135. PubMed ID: 33976722 [TBL] [Abstract][Full Text] [Related]
2. ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo. Li R; Liu T; Shi J; Luan W; Wei X; Yu J; Mao H; Liu P J Transl Med; 2019 Dec; 17(1):428. PubMed ID: 31878941 [TBL] [Abstract][Full Text] [Related]
3. Shikonin impedes type 2 ovarian cancer progression via FasL/caspase-8 and mir-874-3p/XIAP axis and prohibits the properties of stemness. Chang YH; Lin YJ; Huang CY; Harnod T; Ding DC Am J Cancer Res; 2022; 12(10):4584-4601. PubMed ID: 36381333 [TBL] [Abstract][Full Text] [Related]
4. Sensitization of Carboplatinum- and Taxol-Resistant High-Grade Serous Ovarian Cancer Cells Carrying p53, BRCA1/2 Mutations by Emblica officinalis (Amla) via Multiple Targets. De A; De A; Sharma R; Suo W; Sharma M J Cancer; 2020; 11(7):1927-1939. PubMed ID: 32194804 [No Abstract] [Full Text] [Related]
5. Functional characterization of a panel of high-grade serous ovarian cancer cell lines as representative experimental models of the disease. Haley J; Tomar S; Pulliam N; Xiong S; Perkins SM; Karpf AR; Mitra S; Nephew KP; Mitra AK Oncotarget; 2016 May; 7(22):32810-20. PubMed ID: 27147568 [TBL] [Abstract][Full Text] [Related]
6. High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling. Kim D; Choi BH; Ryoo IG; Kwak MK Cell Death Dis; 2018 Aug; 9(9):896. PubMed ID: 30166520 [TBL] [Abstract][Full Text] [Related]
7. The MEK1/2 Pathway as a Therapeutic Target in High-Grade Serous Ovarian Carcinoma. Chesnokov MS; Khan I; Park Y; Ezell J; Mehta G; Yousif A; Hong LJ; Buckanovich RJ; Takahashi A; Chefetz I Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33803586 [TBL] [Abstract][Full Text] [Related]
8. Characterization of aldehyde dehydrogenase 1 high ovarian cancer cells: Towards targeted stem cell therapy. Sharrow AC; Perkins B; Collector MI; Yu W; Simons BW; Jones RJ Gynecol Oncol; 2016 Aug; 142(2):341-8. PubMed ID: 27017984 [TBL] [Abstract][Full Text] [Related]
9. Potential therapeutic effects of N-butylidenephthalide from Radix Angelica Sinensis (Danggui) in human bladder cancer cells. Chiu SC; Chiu TL; Huang SY; Chang SF; Chen SP; Pang CY; Hsieh TF BMC Complement Altern Med; 2017 Dec; 17(1):523. PubMed ID: 29207978 [TBL] [Abstract][Full Text] [Related]
10. ZIP4 Is a Novel Cancer Stem Cell Marker in High-Grade Serous Ovarian Cancer. Fan Q; Zhang W; Emerson RE; Xu Y Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33316986 [TBL] [Abstract][Full Text] [Related]
11. Beyond genomics: critical evaluation of cell line utility for ovarian cancer research. Elias KM; Emori MM; Papp E; MacDuffie E; Konecny GE; Velculescu VE; Drapkin R Gynecol Oncol; 2015 Oct; 139(1):97-103. PubMed ID: 26321251 [TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells. Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286 [TBL] [Abstract][Full Text] [Related]
13. In vivo tumor growth of high-grade serous ovarian cancer cell lines. Mitra AK; Davis DA; Tomar S; Roy L; Gurler H; Xie J; Lantvit DD; Cardenas H; Fang F; Liu Y; Loughran E; Yang J; Sharon Stack M; Emerson RE; Cowden Dahl KD; V Barbolina M; Nephew KP; Matei D; Burdette JE Gynecol Oncol; 2015 Aug; 138(2):372-7. PubMed ID: 26050922 [TBL] [Abstract][Full Text] [Related]
14. Targeting Ovarian Cancer with Chalcone Derivatives: Cytotoxicity and Apoptosis Induction in HGSOC Cells. Merve Aydin E; Canıtez İS; Colombo E; Princiotto S; Passarella D; Dallavalle S; Christodoulou MS; Durmaz Şahin I Molecules; 2023 Nov; 28(23):. PubMed ID: 38067507 [TBL] [Abstract][Full Text] [Related]